Year: 2025
Acumen Pharmaceuticals to Present During International Conference on Alzheimer’s and Parkinson’s Diseases 2025 and American Academy of Neurology Annual Meeting
Written by Customer Service on . Posted in Public Companies.
Acuity Positioned for Growth and Compounding Value
Written by Customer Service on . Posted in Public Companies.
Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025
Written by Customer Service on . Posted in Public Companies.
Corvus Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial of Soquelitinib for Patients with Autoimmune Lymphoproliferative Syndrome (ALPS)
Written by Customer Service on . Posted in Public Companies.
Annual General Meeting 2025 – GN Store Nord A/S
Written by Customer Service on . Posted in Public Companies.
ZyVersa Therapeutics Highlights Data Demonstrating Inflammasome Inhibition Reduces Neuroinflammation and Pathological Brain Deposition of Amyloid Beta in Alzheimer’s Disease Mouse Model
Written by Customer Service on . Posted in Public Companies.
Stack Capital Group Inc. Reports 2024 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Chicago Atlantic Real Estate Finance Announces Fourth Quarter 2024 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.